Husmetabo 7,5 mg Injektionsvätska, lösning i förfylld spruta

Nazione: Svezia

Lingua: svedese

Fonte: Läkemedelsverket (Medical Products Agency)

Scarica Foglio illustrativo (PIL)
19-07-2018
Scarica Scheda tecnica (SPC)
28-04-2018

Principio attivo:

metotrexat

Commercializzato da:

Sigillata Limited

Codice ATC:

L04AX03

INN (Nome Internazionale):

methotrexate

Dosaggio:

7,5 mg

Forma farmaceutica:

Injektionsvätska, lösning i förfylld spruta

Composizione:

metotrexat 7,5 mg Aktiv substans

Classe:

Apotek

Tipo di ricetta:

Receptbelagt

Area terapeutica:

Metotrexat

Dettagli prodotto:

Förpacknings: Förfylld spruta, 4 x 1 st (med fast injektionsnål) (med automatiskt nålskydd och spritsudd); Förfylld spruta, 1 st (med fast injektionsnål) (med automatiskt nålskydd och spritsudd); Förfylld spruta, 1 st (med fast injektionsnål) (med automatiskt nålskydd); Förfylld spruta, 1 st (med fast injektionsnål) (med spritsudd); Förfylld spruta, 1 st (med fast injektionsnål); Förfylld spruta, 4 x 1 st (med fast injektionsnål) (med automatiskt nålskydd); Förfylld spruta, 4 x 1 st (med fast injektionsnål) (med spritsudd); Förfylld spruta, 4 x 1 st (med fast injektionsnål); Förfylld spruta, 12 x 1 st (med fast injektionsnål); Förfylld spruta, 12 x 1 st (med fast injektionsnål) (med automatiskt nålskydd och spritsudd); Förfylld spruta, 12 x 1 st (med fast injektionsnål) (med automatiskt nålskydd); Förfylld spruta, 12 x 1 st (med fast injektionsnål) (med spritsudd)

Stato dell'autorizzazione:

Avregistrerad

Data dell'autorizzazione:

2015-09-24

Foglio illustrativo

                                1
PACKAGE LEAFLET: INFORMATION FOR THE USER
HUSMETABO 2.5 MG, 7.5 MG, 10 MG, 12.5 MG, 15 MG, 17.5 MG, 20 MG, 22.5
MG, 25 MG, 27.5 MG AND
30 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE
methotrexate
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.
-
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Husmetabo is and what it is used for
2.
What you need to know before you use Husmetabo
3.
How to use Husmetabo
4.
Possible side effects
5.
How to store Husmetabo
6.
Contents of the pack and other information
1.
WHAT HUSMETABO IS AND WHAT IT IS USED FOR
Husmetabo contains methotrexate as active substance.
Methotrexate is a substance with the following properties:
-
it interferes with the growth of certain cells in the body that
reproduce quickly
-
it reduces the activity of the immune system (the body’s own defence
mechanism)
-
it has anti-inflammatory effects.
Husmetabo is indicated for the treatment of
-
active rheumatoid arthritis in adult patients.
-
polyarthritic forms of severe, active juvenile idiopathic arthritis,
when the response to
nonsteroidal anti-inflammatory drugs (NSAIDs) has been inadequate.
-
severe recalcitrant disabling psoriasis, which is not adequately
responsive to other forms of
therapy such as phototherapy, PUVA, and retinoids, and severe
psoriatic arthritis in adult
patients.
-
mild to moderate Crohn’s disease in adult patients when adequate
treatment with other
medicines is not possible.
Rheumatoid arthritis (RA)
is a chronic collagen disease, characterised by inflammation of the
synovial membranes (joint membranes). These
                                
                                Leggi il documento completo
                                
                            

Scheda tecnica

                                MARKNADSFÖRS EJ FÖR NÄRVARANDE.
_Produktinformation_
                                
                                Leggi il documento completo
                                
                            

Documenti in altre lingue

Foglio illustrativo Foglio illustrativo inglese 14-04-2021
Scheda tecnica Scheda tecnica inglese 28-09-2020